University of Colorado Boulder Computer Science Department

New ODU Partnership with HII-NNS Aims to Increase Engineering Majors

Retrieved on: 
Tuesday, October 24, 2023

NNS, the largest industrial employer in Virginia and a division of the largest shipbuilding company in the United States, will be the lead industry sponsor of the Monarch Accelerator Program to Engineering (MAP-to-E), which aims to increase the number of engineering and engineering technology majors and degrees, particularly from underrepresented and underserved communities in Hampton Roads.

Key Points: 
  • NNS, the largest industrial employer in Virginia and a division of the largest shipbuilding company in the United States, will be the lead industry sponsor of the Monarch Accelerator Program to Engineering (MAP-to-E), which aims to increase the number of engineering and engineering technology majors and degrees, particularly from underrepresented and underserved communities in Hampton Roads.
  • NNS will make a five-year gift to the program with an invitation to renew for another five-year term.
  • “These students, through no fault of their own, have not had the opportunity to be adequately prepared to transition directly into an engineering program upon entering college.”
    The Monarch Accelerator Program to Engineering aims to:
    Increase the number of full-time engineering and engineering-related students enrolled at ODU.
  • Increase the number of diverse and first-generation students pursuing careers in engineering and engineering-related systems.

Ashvattha Therapeutics Announces Appointment of Dr. Sakura Minami as Vice President of Translational Medicine and Nonclinical Development and Sarah Thayer as Head of Clinical Operations

Retrieved on: 
Monday, October 9, 2023

REDWOOD CITY, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells in regions of inflammation, today announced the appointment of Sakura Minami, Ph.D., as Vice President of Translational Medicine and Nonclinical Development and Sarah Thayer as Head of Clinical Operations.

Key Points: 
  • REDWOOD CITY, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells in regions of inflammation, today announced the appointment of Sakura Minami, Ph.D., as Vice President of Translational Medicine and Nonclinical Development and Sarah Thayer as Head of Clinical Operations.
  • Ms. Thayer has more than 20 years of progressive leadership experience in clinical development operations across various therapeutic areas from Phase 1 through Phase 3.
  • She previously served as Vice President, Head of Clinical Operations at Recode Therapeutics where she established the clinical operations function at the company.
  • Prior to Recode, she led clinical operations at Global Blood Therapeutics (Pfizer), StemCells Inc, FivePrime Therapeutics (Amgen), CV Therapeutics (Gilead), Titan Pharmaceuticals and Becton Dickinson Immunocytometry Systems.

Wallaroo.AI Receives Small Business Technology Transfer Award to Advance AI On-Orbit

Retrieved on: 
Tuesday, August 15, 2023

The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution.

Key Points: 
  • The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution.
  • By leveraging AI at the edge, Wallaroo.AI empowers the US Space Force, the primary beneficiary of this groundbreaking project.
  • This revolutionary development promises to transform automation in space by leveraging AI for robotics, refueling, and protecting satellites from space debris.
  • Wallaroo.AI was among only 20 companies chosen for the Phase II program, highlighting its leadership in the field.

Abu Dhabi’s artificial intelligence university establishes dedicated robotics and computer science departments to meet surging global demand

Retrieved on: 
Thursday, August 3, 2023

The new departments complement the university’s existing computer vision (CV), machine learning (ML), and natural language processing (NLP) departments, which are ranked among the top 20 globally by CSRankings.

Key Points: 
  • The new departments complement the university’s existing computer vision (CV), machine learning (ML), and natural language processing (NLP) departments, which are ranked among the top 20 globally by CSRankings.
  • Aligned with the formation of the new departments, the university has launched master’s and Ph.D. programs in robotics and computer science.
  • MBZUAI President and University Professor, Eric Xing, said: "The addition of these two new departments represents MBZUAI’s lasting effort in developing a solid foundation for research excellence and innovation in artificial intelligence.
  • Research indicates strong demand for robotics expertise in the coming years, with the robotics technology market expected to surpass US$225.6 billion in value by 2030iii.

Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry

Retrieved on: 
Tuesday, May 16, 2023

CAMBRIDGE, Mass., May 16, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. Two years into development, Flagship has made an initial commitment of $50 million to advance Metaphore's MIMiC™ platform and build its pipeline for patients with autoimmune, metabolic, or oncology indications.

Key Points: 
  • With $50 million in committed capital from Flagship, Metaphore has built a first-in-class bioplatform during the past two years
    CAMBRIDGE, Mass., May 16, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics.
  • said Noubar Afeyan, Ph.D., Founder and CEO of Flagship Pioneering and Co-Founder and Chairman of Metaphore.
  • We believe this approach has the potential to unlock breakthroughs that outperform today's drugs and reach patients with few or no therapeutic options."
  • Metaphore's leadership team includes Amanda Kay, Ph.D., Flagship Pioneering Operating Partner and President of Metaphore, former CBO Deep Genomics, and COO Pfizer Inflammation & Immunology; Chaz Hinzman, Ph.D., Flagship Pioneering Associate and Head of Business Operations for Metaphore; and Marcin Paduch, Ph.D., Head of Platform at Metaphore.

AI is exciting – and an ethical minefield: 4 essential reads on the risks and concerns about this technology

Retrieved on: 
Friday, April 28, 2023

Large-language models, generative AI, algorithmic bias – it’s a lot for the less tech-savvy of us to sort out, trying to make sense of the myriad headlines about artificial intelligence swirling about.

Key Points: 
  • Large-language models, generative AI, algorithmic bias – it’s a lot for the less tech-savvy of us to sort out, trying to make sense of the myriad headlines about artificial intelligence swirling about.
  • As a society, we’re also confronting concerns about its social, psychological and ethical effects.

1. Ethical debt

    • More alarming, though, is “ethical debt,” when development teams haven’t considered possible social or ethical harms – how AI could replace human jobs, for example, or when algorithms end up reinforcing biases.
    • When it comes to ethical debt, she noted, “the people who incur it are rarely the people who pay for it in the end.”

      Read more:
      AI has social consequences, but who pays the price?

    • Tech companies' problem with 'ethical debt'

2. Is anybody there?

    • “ChatGPT and similar technologies are sophisticated sentence completion applications – nothing more, nothing less,” he wrote.
    • The next steps, though, are “strong guardrails” to prevent programs from taking advantage of that emotional connection.
    • Read more:
      AI isn't close to becoming sentient – the real danger lies in how easily we're prone to anthropomorphize it

3. Putting pen to paper

    • How could educators – or college admissions officers, for that matter – figure out if an essay was written by a human or a chatbot?
    • But AI sparks more fundamental questions about writing, according to Naomi Baron, an American University linguist who studies technology’s effects on language.
    • AI’s potential threat to writing isn’t just about honesty, but about the ability to think itself.

4. The value of art

MedCrypt Funds Medical Device Usable Security Research at the School of Engineering at Tufts University

Retrieved on: 
Tuesday, April 25, 2023

SAN DIEGO, April 25, 2023 /PRNewswire/ -- MedCrypt, Inc., the proactive cybersecurity solutions provider for medical device manufacturers, today announced its financing of the School of Engineering for a Tufts University fellowship program that will support research focusing on the investigation of medical device security and threat modeling.

Key Points: 
  • Daniel Votipka is an assistant professor of two years in the Computer Science Department in the School of Engineering at Tufts University and the director of the Tufts Security and Privacy Lab and has almost a decade of cybersecurity research experience.
  • His research focuses on computer security, with an emphasis on the human factors affecting security professionals.
  • "We are excited that MedCrypt has chosen to support our research investigating the challenges of effective threat modeling for medical devices," said Professor Votipka.
  • By taking a hypothesis-driven approach, the findings from this research fellowship could inform sustainable, scalable advances in medical device security processes.

Generative AI: 5 essential reads about the new era of creativity, job anxiety, misinformation, bias and plagiarism

Retrieved on: 
Wednesday, April 19, 2023

Think facial recognition, algorithms making loan and sentencing recommendations, and medical image analysis.

Key Points: 
  • Think facial recognition, algorithms making loan and sentencing recommendations, and medical image analysis.
  • Here are five articles from our archives the take the measure of this new generation of artificial intelligence.

1. Generative AI and work

    • A panel of five AI experts discussed the implications of generative AI for artists and knowledge workers.
    • University of Tennessee computer scientist Lynne Parker wrote that while there are significant benefits to generative AI, like making creativity and knowledge work more accessible, the new tools also have downsides.
    • The question is whether society will use this moment to advance equity or exacerbate disparities.”

      Read more:
      AI and the future of work: 5 experts on what ChatGPT, DALL-E and other AI tools mean for artists and knowledge workers

2. Conjuring images from words

    • It’s hard to imagine how image-generating AIs can take a few words of text and produce an image that matches the words.
    • The software is trained on a massive set of images, each of which includes a short text description.

3. Marking the machine

    • Many of the images produced by generative AI are difficult to distinguish from photographs, and AI-generated video is rapidly improving.
    • Fake videos of corporate executives could be used to manipulate stock prices, and fake videos of political leaders could be used to spread dangerous misinformation.

4. Flood of ideas

    • People in creative fields can use the image generators to quickly sketch out ideas, including unexpected off-the-wall material.
    • Rochester Institute of Technology industrial designer and professor Juan Noguera and his students use tools like DALL-E or Midjourney to produce thousands of images from abstract ideas – a sort of sketchbook on steroids.
    • “Enter any sentence – no matter how crazy – and you’ll receive a set of unique images generated just for you.

5. Shortchanging the creative process

The University of Arizona Global Campus Presents ED Talks® 2023

Retrieved on: 
Thursday, March 2, 2023

CHANDLER, Ariz., March 2, 2023 /PRNewswire/ -- The College of Arts and Sciences Department of Education and Liberal Arts at the University of Arizona Global Campus (UAGC) is proud to present the 9th Annual ED Talks® series.

Key Points: 
  • CHANDLER, Ariz., March 2, 2023 /PRNewswire/ -- The College of Arts and Sciences Department of Education and Liberal Arts at the University of Arizona Global Campus (UAGC) is proud to present the 9th Annual ED Talks® series.
  • Just as a planted seed grows, the skills and lessons learned will transcend the online higher education classroom.
  • With seven sessions in TED Talks monologue format, each discussion examines principles through the lens of 'Seed and Sower' to develop the mindset aimed at maximizing potential and promoting growth and achievement for learners in the online higher education environment.
  • NO ED TALK® IN JULY – See you in August!

The Foundation for Sarcoidosis Research (FSR) to provide $50,000 in Sarcoidosis Research Funding Exploring Environmental Causes of sarcoidosis and for Identifying Neurosarc Biomarkers

Retrieved on: 
Thursday, November 24, 2022

CHICAGO, Nov. 23, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the funding for two new pilot projects in sarcoidosis.

Key Points: 
  • CHICAGO, Nov. 23, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the funding for two new pilot projects in sarcoidosis.
  • These research projects show great promise in advancing the understanding, diagnosis, and management of sarcoidosis.
  • FSR is dedicated to accelerating sarcoidosis research through fellowships, small grants, large grants, and disease specific grants to advance sarcoidosis research and advance care for those living with sarcoidosis.
  • The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and to improving care for sarcoidosis patients through research, education, and support.